Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Moi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annali Dell'Istituto Superiore Di Sanita|March 21, 2003
[MDMA (ecstasy): neuroendocrine and behavioral features]Gilberto Gerra, Amir Zaimovic, Gabriele Moi, et al.
Psychiatry Research|November 30, 2006
Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjectsGilberto Gerra, Amir Zaimovic, Maria Augusta Raggi, et al.
Psychiatry Research|October 7, 2003
Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivityGilberto Gerra, Sara Bassignana, Amir Zaimovic, et al.
International Clinical Psychopharmacology|August 16, 2003
Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traitsGilberto Gerra, Simona Ceresini, Assunta Esposito, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Aggressive responding in abstinent heroin addicts: neuroendocrine and personality correlatesGilberto Gerra, Amir Zaimovic, Gabriele Moi, et al.
Behavioural Brain Research|August 23, 2002
Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humansGilberto Gerra, Amir Zaimovic, Gabriele Moi, et al.
Addiction Biology|August 20, 2005
Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin-dependent patientsGilberto Gerra, Luciano Garofano, Caterina Pellegrini, et al.
Clinical Neuropharmacology|June 5, 2007
Combination of olanzapine with opioid-agonists in the treatment of heroin-addicted patients affected by comorbid schizophrenia spectrum disordersGilberto Gerra, Gilberto Di Petta, Antonio D'Amore, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annali Dell'Istituto Superiore Di Sanita|March 21, 2003
[MDMA (ecstasy): neuroendocrine and behavioral features]Gilberto Gerra, Amir Zaimovic, Gabriele Moi, et al.
Psychiatry Research|November 30, 2006
Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjectsGilberto Gerra, Amir Zaimovic, Maria Augusta Raggi, et al.
Psychiatry Research|October 7, 2003
Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivityGilberto Gerra, Sara Bassignana, Amir Zaimovic, et al.
International Clinical Psychopharmacology|August 16, 2003
Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traitsGilberto Gerra, Simona Ceresini, Assunta Esposito, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Aggressive responding in abstinent heroin addicts: neuroendocrine and personality correlatesGilberto Gerra, Amir Zaimovic, Gabriele Moi, et al.
Behavioural Brain Research|August 23, 2002
Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humansGilberto Gerra, Amir Zaimovic, Gabriele Moi, et al.
Addiction Biology|August 20, 2005
Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin-dependent patientsGilberto Gerra, Luciano Garofano, Caterina Pellegrini, et al.
Clinical Neuropharmacology|June 5, 2007
Combination of olanzapine with opioid-agonists in the treatment of heroin-addicted patients affected by comorbid schizophrenia spectrum disordersGilberto Gerra, Gilberto Di Petta, Antonio D'Amore, et al.
Pageof 1